If we look at the acquisitions, JVs, the shareholder issues, privatisation, removing founders, diverse teams in diff locations and companies etc etc......it seems unrealistic to think that the new CEO in 3 mths has resolved all of this and got the company back to (cashflow positive) growth.
At best, stabilise revenues, reduce cash burn, align the teams around priority products (sales, enhancements, etc) and then grow off that stable platform
Add to that these products are enterprise level sales, and looking at the broader economic backdrop, it seems unlikely that many companies are making huge changes to their product suite unless there is a very compelling reason to do so
- Forums
- ASX - By Stock
- LVT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-112
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online